Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.

Bolus 5-fluorouracil (5-FU) is a phase-specific drug with a short plasma half-life that is used in combination with bolus cyclophosphamide and methotrexate in the treatment of breast cancer. The efficacy of 5-FU can be improved by continuous intravenous infusion using portable infusion pumps (infusi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: O'Byrne, K. J., Koukourakis, M. I., Saunders, M. P., Salisbury, A. J., Isaacs, R., Varcoe, S., Taylor, M., Ganesan, T. S., Harris, A. L., Talbot, D. C.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1998
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2150339/
https://ncbi.nlm.nih.gov/pubmed/9667673
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires